小摩增持信达生物约143.88万股 每股作价约84.73港元

Group 1 - JPMorgan increased its stake in Innovent Biologics (01801) by acquiring 1,438,757 shares at a price of HKD 84.7327 per share, totaling approximately HKD 122 million [1] - Following the acquisition, JPMorgan's total shareholding in Innovent Biologics is approximately 86,841,100 shares, representing a stake of 5.06% [1]